Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a maintenance/versioning update that does not modify the study details or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-lapse notice (v3.4.1) was removed. There are no changes to the core study details, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T02:12:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is added, informing users that the site may not be up to date and inquiries may be delayed, along with a status note about the NIH Clinical Center's operating status; the page revision changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-02-04T01:52:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI and metadata updates were made: glossary toggle visibility added, Last Update Submitted that Met QC Criteria label updated, No FEAR Act Data capitalization adjusted, and a new revision tag v3.4.0 introduced, with older items like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision v3.3.4 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T00:30:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The revision label in the page footer changed from v3.3.3 to v3.3.4. No substantive content or functionality changes are observed in the screenshots.
    Difference
    0.1%
    Check dated 2026-01-14T01:25:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:37:28.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.